NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS

Clinical trials for NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS explained in plain language.

Never miss a new study

Get alerted when new NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS trials appear

Sign up with your email to follow new studies for NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Scientists reprogram Patients' own cells to hunt cancer

Disease control Ongoing

This early-stage study tests a personalized cell therapy for people with advanced solid tumors. Doctors collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer, then infuse them back into the patient. The main goals are to chec…

Matched conditions: NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS

Phase: PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS

Get alerted when new NY-ESO-1 EXPRESSING SOLID TUMORS IN HLA-A2 POSITIVE PATIENTS trials appear

Scientists reprogram Patients' own cells to hunt cancer